Journal List > Korean J Neurotrauma > v.15(2) > 1136045

Nikova, Sioutas, Kotopoulos, Ganchev, Chatzipaulou, and Birbilis: The Clock Is Ticking – Brain Atrophy in Case of Acute Trauma?

Abstract

Objective

Brain atrophy and brain herniation are gaining a lot of attention separately, but a limited amount of studies connected them together, and because of this, we are going to review and examine the subject in the current meta-analysis.

Methods

The authors collected data reporting brain atrophy of alcoholic and schizophrenic cause, as well as data on control patients, all of which was published on MEDLINE between 1996 and 2018. The included 11 articles were processed with a statistical program.

Results

We found that the pericerebral space is unequal among the groups, while the intracranial volume is strongly correlated to the biggest foramen of the body. The effect of this inequality, however, is expressed in emergency cases, where the patients with brain atrophy will have more time before the final stage of brain herniation.

Conclusion

The current study raises a controversial issue that requires careful investigation and high attention from the health care personnel.

INTRODUCTION

Atrophy is a word suggesting degeneration and decline of function, regardless if it is used for an anatomical structure or as a metaphor of the speech. It also affects the brain, disrupting its structural balance and performance. Plenty of diseases, external factors and genetic predispositions are suggested as cause of the condition.
Meanwhile, brain herniation is a fatal result after an acute increase of the intracranial pressure (ICP), more often due to traumatic brain injury (TBI) or acute brain bleed. In normal condition a person has 75 mL entrant cerebrospinal fluid (CSF) at every 5 seconds and 100–130 mL entrant blood flow. The 14% of the cardiac output reaches the brain. In normal conditions (no bleed, tumor or other cause of increased brain volume [BV]) a person has ICP at about 5–10 mmHg. Every cause of increased brain pressure according to the Monro-Kellie doctrine leads to compensatory mechanisms, where the entrant fluids are reduced in order to maintain normal ICP. When the extra BV extends the 100–120 mL, the compensatory mechanisms do not work, leading to increased ICP and brain herniation.
At first sight, the aforementioned processes seem unrelated. Reviewing them, however, one understands that BV, pericerebral space (PICS) and intracranial volume (ICV) are related to brain herniation, because of their close relation and interaction. Hence, this raises a question. If these parameters are related, are they equal? And if this relation between them exists, how does this affect us? The aim of the current study is to try to answer this question.

MATERIALS AND METHODS

In order to describe the relation between atrophy and herniation, 2 independent authors collected studies reporting brain atrophy caused by alcoholic and schizophrenic factors, all of which were found on Medline, Embase, Cochraine, Willey, Google Scholar and from the references of the articles found, between 1996 and 2018. The main reason those specific entities were chosen was that atrophy in schizophrenia is considered to be regional, allowing the examination of more than one type of atrophy, and that alcohol is the most common cause of atrophy due to substance abuse.
MeSH terms used for the search were: brain atrophy, alcohol, schizophrenia, BV, ICV and foramen magnum (FM).
Two independent authors collected the studies, while a third author analyzed the data.
Inclusion criteria were: i) human studies; ii) English language studies; iii) clinical studies; and iv) articles reporting BV and ICV or ICV and Grey and white matter, all of which are reported in mL or cm3 and demographics of the patients.
On the other hand, exclusion criteria were: i) non-human studies; ii) non-English studies; iii) case reports; iv) comments; v) letters to editor; vi) reviews; vii) meta-analyses; viii) studies reporting only partial data of the brain capacity or brain capacity in Liters; ix) articles with no demographic data; x) articles with mean age of the participants under 19 or over 60 years; and xi) other causes of brain atrophy, except of the aforementioned (FIGURE 1).
FIGURE 1

Flow chart.

kjn-15-117-g001
The attached studies were strictly selected based on the criteria and afterwards the data extracted from each study was divided into 3 categories—controls, alcoholic patients, and schizophrenic patients. Data collected from the studies included age, BV, ICV, FM's surface area (FMSA), and PICS.
In the case of only grey matter (GM) and white matter (WM) volume, the authors used the formula below to calculate the BV.
BV=GM+WM
The PICS and FMSA were not reported, and we calculated them as it follows1):
PICS=ICV-BVICVorPICS(%)=ICV-BVICV×1100kjn-15-117-e001.jpg
FMSA=18.44 +(0.565×ICV [cm3])
Thereafter, the data was analyzed with Bayesian paired t-test and correlation analysis on Jeffreys's Amazing Statistics Program (JASP) statistical program. The Bayesian paired t-test is equal to the paired student t-test, estimating the mean of 2 groups.

RESULTS

For the final results, the authors included 11 studies with a total number of 849 patients (TABLE 1 & FIGURE 1).245610222425313234) The studies were divided into 3 groups: controls, alcoholic and schizophrenic patients. The mean age of the controls, the patients with alcohol abuse, and the patients with schizophrenia were 38.61, 47.5, and 33.65, respectively.
TABLE 1

List of included studies

kjn-15-117-i001
Study Age (year) BV (cm3) ICV (cm3) PICS (%) Group
Matsumae et al.22) 50 1,227 1,384 9.39 Controls
Reite et al.32) 34.34 1,281 1,413 9.34 Controls
39.22 1,260 1,402 10.13 Schizophrenic
Agartz et al.2) 47.7 1,228 1,560 21.12 Alcoholic
Mechtcheriakov et al.24) 53.6 1,102 1,668 33.92 Controls
1,005 1,718 41.47 Alcoholic
Collin et al.10) 28.9 1,111 1,269 12.42 Schizophrenic
36.4 1,116 1,274 12.67 Controls
Bjork et al.5) 40.1 1,067 1,353 21.14 Alcoholic
1,126 1,377 18.17 Controls
Andreone et al.4) 40.6 938 1,058 11.29 Schizophrenic
40.2 1,007 1,134 11.17 Controls
Mon et al.25) 50.2 620 1,488 58.33 Alcoholic
Boonstra et al.6) 27.97 1,181 1,365 13.44 Controls
28.8 1,147 1,333 13.94 Schizophrenic
Sullivan et al.34) 41.3 1,290 1,354 4.75 Controls
40 1,240 1,325 6.39 Schizophrenic
44.6 1,260 1,332 5.41 Alcoholic
Rais et al.31) 24.39 1,263 1,518 16.8 Schizophrenic
23.7 1,327 1,550 14.39 Controls
Afterwards, Bayesian paired t-test was performed with Bayes factor linking to the alternative hypothesis (BF10) (alternative hypothesis is A≠B).
The results reveal very interesting facts (TABLE 2). Pericerebral space appeared to be equal among controls and schizophrenic patients, unequal between controls and alcoholic patients and unequal between schizophrenic and alcoholic patients. The Bayesian plot, FIGURE 2, shows that the alternative hypothesis (H1) or the inequality between A and B is accepted in the cases of alcoholic atrophy, while the null hypothesis (H0) is accepted only between the normal subjects and schizophrenics. The outcome suggests that the pericerebral space in the case of schizophrenia-related atrophy (regional) is the same as the one in normal individuals, while PICS in alcohol-related atrophy (diffuse atrophy) is unequal.
TABLE 2

Bayesian paired t-test

kjn-15-117-i002
Groups PICS
BF10 Error (%)
Control vs. Schizophrenic 1.313 8.164e-4
Schizophrenic vs. Alcoholic 2.251 0.002
Control vs. Alcoholic 0.727 0.014
PICS: pericerebral space, BF10: Bayes factor.
FIGURE 2

Bayesian paired t-test–PICS plot.

PICS: pericerebral space, BF10: Bayes factor.
kjn-15-117-g002
After the correlation analysis FMSA and ICV were found to be correlated with strong, positive correlation in all of the groups. (TABLES 3, 4, 5). This means that by increasing the ICV the space between the bony tissue of the FM and the nerve tissue will thicken, since the FM' opening could not grow bigger.
TABLE 3

Correlation matrix controls

kjn-15-117-i003
Pearson correlations PICS Age FM ICV
Age
Pearson's e 0.388 - - -
p-value 0.302 - - -
FM
Pearson's r 0.610 0.110 - -
p-value 0.081 0.778 - -
ICV
Pearson's r 0.660 0.141 0.987 -
p-value 0.053* 0.718 <0.001* -
BV
Pearson's r −0.400 −0.388 0.466 0.419
p-value 0.287 0.302 0.207 0.262
PICS: pericerebral space, FM: foramen magnum, ICV: intracranial volume, BV: brain volume.
*Significant p-value.
TABLE 4

Correlation matrix of alcohol atrophy

kjn-15-117-i004
Pearson correlations PICS FM Age ICV
FM
Pearson's r 0.233 - - -
p-value 0.490 - - -
Age
Pearson's r 0.443 0.421 - -
p-value 0.172 0.197 - -
ICV
Pearson's r 0.239 1.000* 0.420 -
p-value 0.479 <0.001* 0.198 -
BV
Pearson's r −0.889 0.233 −0.250 0.228
p-value <0.001 0.491 0.458 0.500
PICS: pericerebral space, FM: foramen magnum, ICV: intracranial volume, BV: brain volume.
*Significant p-value.
TABLE 5

Correlation matrix of schizophrenic atrophy

kjn-15-117-i005
Pearson correlations PICS BV ICV Age
FM
r 0.278 0.943 0.989 −0.437
p-value 0.594 0.005* <0.001* 0.386
AGE
r −0.865 - - -
p-value 0.026* - - -
BV
R −0.031 - - −0.227
p-value 0.953 - - 0.666
ICV
R 0.334 0.931 - −0.526
p-value 0.517 0.007* - 0.284
PICS: pericerebral space, FM: foramen magnum, ICV: intracranial volume, BV: brain volume.
*Significant p-value.
No matter which group has smaller or greater volumes, the result is that there is inequality between the groups, in different analogues. Also, the FM, as an anatomical structure, has specific size, diameter and surface area.92728) In normal patient the ICV is occupied from brain tissue, blood and CSF, as the FM and has ICP between 5 and 10 mmHg.
In case of epidural/ subdural hematoma, brain trauma or other cause of increased intracranial brain pressure, according to the Monroe-Kellie dogma, CSF and blood would be first released in order ICP to be balanced. Approximately every 5 seconds the entrant CSF is 75 mL, while the entrant blood flow 100–130 mL (1/5 arterial, 2/3 venous, and 2/3 in the microcirculation).
The mechanism of Monroe-Kellie cannot maintain normal pressure when the increase of volume extends 120–130 mL. As a result, the ICV would increase, as well as the ICP. Since the cranium is a closed “box,” except of the single opening of FM, the increase of the ICV and ICP will cause the brain to prolapse with final stage of herniation—through the FM.
In case of brain atrophy, the balance of the ICV is maintained with increased CSF, while the PICS appears bigger. Clinically, because of the differences among the PICS and BVs, and the standard size of the FM, some of those patients would have more space between the brain tissue and bone's edge, and they would theoretically develop brain herniation and probably the symptomatology of ICP and ischemia with a time-delay. Something similar is observed among elderly patients with chronic subdural hematoma, where the age-related atrophy makes space for the hematoma, and many do not show any symptoms of it, until a recurrent bleed occurs.
This states an important probability fact, requiring more investigation, but also an issue that should be considered for the first hours of management of the traumatic brain injuries and preventive measures for the general population.

DISCUSSION

The human cranial skeleton is a complex structure made up of bones and cartilages that derive from the neural crest and mesoderm.15) It consists of 2 main parts, the neurocranium and the viscerocranium, encircling the brain, and shaping the face, respectively. As far as the neurocranium is concerned, it can be further sub classified into skull base, chondrocranium and calvaria.1536) According to Raam et al.30) the adult cranial vault is made of eight separate bones. The “joints” of the cranial vault play also a major role to the separate bones of the last, holding them tight together and allowing the growth of the skull.1530)
The skull cavity encloses brain tissue, including meninges, cerebrospinal fluid, vessels and nerves. The final size of the ICV is reached at the age of 16–20 years old and it is believed that it remains constant thereafter.1737) The average BV of a well-nourished European is about 1,260 cm3 for males and 1,130 cm3 for females. There are differences between the sexes due to differences in height and size.311)
According to Zdilla et.al.38) the mean FMSA is about 864 mm2. Moreover, between the FM area and dimensions there are major dissimilarities among the ethnicities and sexes. Generally, males have a considerably bigger transverse and sagittal lengths than female individuals. As a result, an important distinction is observed in the FM area between the both sexes (98.78 mm2), but no such distinction in the foramen's perimeters (t=1.785).
Finally, according to Acer et al.1) the ICV's mean was estimated at 1,311 cm3. A positive association (r=0.271, p=0.005) was established between ICV and FMSA. These results are the same as the ones of the current study. Furthermore, the p-value of this analysis is <0.001, while the R2=1, indicating even stronger relation between ICV and FMSA.
Atrophy, in this respect, is an end-stage status for many diseases, including substances' abuse, dementia, infections, neurological, systematic, psychiatric, and posttraumatic conditions.713142021262935) Furthermore, there is a normal age-related loss of BV evaluated at 0.1–0.3% per year.12) Moderate to severe brain atrophy specifically protects from the development of malignant middle cerebral artery infarction.23) This happens, because cerebral atrophy provides a compensatory intracranial space for the increase in volume and protects from regionally increase of the ICP, thus, protects patients with atrophy from herniation and death after a large cerebral infarct.19) Apart from the general protection from fatal brain herniation in patients with intracerebral hemorrhage, brain atrophy also protects patients with basal ganglia hemorrhage, and after such, it is used as a prognostic factor for the final functional outcome.1618)
Brain herniation, as stated above, is a fatal condition, where the brain tissue and nerves are compressed, the vessels are obstructed and the ICP is highly increased. The management of the herniation, however, is suggested to be as rapid as possible. The recommendations833) suggest that neurosurgical procedure is equal to a “gold standard.” Mannitol is used in the beginning, but a quite high percentage of the individuals with severe traumatic brain injury will require surgery to prevent brain herniation. There are four types of brain herniation based on the anatomical region that is injured. Final stage, however, is the central herniation through the FM.
According to this analysis, the PICS' are different among the studied groups. The main idea is that, in case of brain injury, where the capacity of the “box” containing blood, CSF and the normal brain tissue is suppressed, the ICV could not grow independently, but a brain herniation would develop. In those cases, people with brain atrophy, because of the differences in the volumes, would have more space, thereafter a delayed fatal result. And in those cases, the “rapid management” could prevent death.

CONCLUSION

In conclusion, the study presents a theoretical suggestion that brain atrophy could be a protector of brain herniation. Since the condition itself is due to other pathological processes, it requires further investigation and high attention from the health care personnel, not only because it would require reevaluation of the brain trauma guidelines, but also different therapeutical approaches.

Notes

Conflict of Interest: The authors have no financial conflicts of interests.

References

1. Acer N, Sahin B, Ekinci N, Ergür H, Basaloglu H. Relation between intracranial volume and the surface area of the foramen magnum. J Craniofac Surg. 2006; 17:326–330. PMID: 16633182.
crossref
2. Agartz I, Brag S, Franck J, Hammarberg A, Okugawa G, Svinhufvud K, et al. MR volumetry during acute alcohol withdrawal and abstinence: a descriptive study. Alcohol Alcohol. 2003; 38:71–78. PMID: 12554612.
crossref
3. Allen JS, Damasio H, Grabowski TJ. Normal neuroanatomical variation in the human brain: an MRI-volumetric study. Am J Phys Anthropol. 2002; 118:341–358. PMID: 12124914.
crossref
4. Andreone N, Tansella M, Cerini R, Rambaldelli G, Versace A, Marrella G, et al. Cerebral atrophy and white matter disruption in chronic schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2007; 257:3–11. PMID: 16960652.
crossref
5. Bjork JM, Grant SJ, Hommer DW. Cross-sectional volumetric analysis of brain atrophy in alcohol dependence: effects of drinking history and comorbid substance use disorder. Am J Psychiatry. 2003; 160:2038–2045. PMID: 14594753.
crossref
6. Boonstra G, van Haren NE, Schnack HG, Cahn W, Burger H, Boersma M, et al. Brain volume changes after withdrawal of atypical antipsychotics in patients with first-episode schizophrenia. J Clin Psychopharmacol. 2011; 31:146–153. PMID: 21346618.
crossref
7. Burton EJ, McKeith IG, Burn DJ, Williams ED, O'Brien JT. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain. 2004; 127:791–800. PMID: 14749292.
crossref
8. Carney N, Totten AM, O'Reilly C, Ullman JS, Hawryluk GW, Bell MJ, et al. Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition. Neurosurgery. 2017; 80:6–15. PMID: 27654000.
crossref
9. Chethan P, Prakash KG, Murlimanju BV, Prashanth KU, Prabhu LV, Saralaya VV, et al. Morphological analysis and morphometry of the foramen magnum: an anatomical investigation. Turk Neurosurg. 2012; 22:416–419. PMID: 22843456.
crossref
10. Collin G, Derks EM, van Haren NE, Schnack HG, Hulshoff Pol HE, Kahn RS, et al. Symptom dimensions are associated with progressive brain volume changes in schizophrenia. Schizophr Res. 2012; 138:171–176. PMID: 22534419.
crossref
11. Cosgrove KP, Mazure CM, Staley JK. Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry. 2007; 62:847–855. PMID: 17544382.
crossref
12. De Stefano N, Airas L, Grigoriadis N, Mattle HP, O'Riordan J, Oreja-Guevara C, et al. Clinical relevance of brain volume measures in multiple sclerosis. CNS Drugs. 2014; 28:147–156. PMID: 24446248.
crossref
13. Focke NK, Kallenberg K, Mohr A, Djukic M, Nau R, Schmidt H. Distributed, limbic gray matter atrophy in patients after bacterial meningitis. AJNR Am J Neuroradiol. 2013; 34:1164–1167. PMID: 23194831.
crossref
14. Jáuregui-Lobera I. Neuroimaging in eating disorders. Neuropsychiatr Dis Treat. 2011; 7:577–584. PMID: 22003297.
crossref
15. Jin SW, Sim KB, Kim SD. Development and growth of the normal cranial vault: an embryologic review. J Korean Neurosurg Soc. 2016; 59:192–196. PMID: 27226848.
16. Kalita J, Misra UK, Vajpeyee A, Phadke RV, Handique A, Salwani V. Brain herniations in patients with intracerebral hemorrhage. Acta Neurol Scand. 2009; 119:254–260. PMID: 19053952.
crossref
17. Knutson B, Momenan R, Rawlings RR, Fong GW, Hommer D. Negative association of neuroticism with brain volume ratio in healthy humans. Biol Psychiatry. 2001; 50:685–690. PMID: 11704075.
crossref
18. Kwon SM, Choi KS, Yi HJ, Ko Y, Kim YS, Bak KH, et al. Impact of brain atrophy on 90-day functional outcome after moderate-volume basal ganglia hemorrhage. Sci Rep. 2018; 8:4819. PMID: 29555930.
crossref
19. Lee SH, Oh CW, Han JH, Kim CY, Kwon OK, Son YJ, et al. The effect of brain atrophy on outcome after a large cerebral infarction. J Neurol Neurosurg Psychiatry. 2010; 81:1316–1321. PMID: 20650914.
crossref
20. MacKenzie JD, Siddiqi F, Babb JS, Bagley LJ, Mannon LJ, Sinson GP, et al. Brain atrophy in mild or moderate traumatic brain injury: a longitudinal quantitative analysis. AJNR Am J Neuroradiol. 2002; 23:1509–1515. PMID: 12372740.
21. Maia da Silva MN, Millington RS, Bridge H, James-Galton M, Plant GT. Visual dysfunction in posterior cortical atrophy. Front Neurol. 2017; 8:389. PMID: 28861031.
crossref
22. Matsumae M, Kikinis R, Mórocz IA, Lorenzo AV, Sándor T, Albert MS, et al. Age-related changes in intracranial compartment volumes in normal adults assessed by magnetic resonance imaging. J Neurosurg. 1996; 84:982–991. PMID: 8847593.
crossref
23. Minnerup J, Wersching H, Ringelstein EB, Heindel W, Niederstadt T, Schilling M, et al. Prediction of malignant middle cerebral artery infarction using computed tomography-based intracranial volume reserve measurements. Stroke. 2011; 42:3403–3409. PMID: 21903965.
crossref
24. Mechtcheriakov S, Brenneis C, Egger K, Koppelstaetter F, Schocke M, Marksteiner J. A widespread distinct pattern of cerebral atrophy in patients with alcohol addiction revealed by voxel-based morphometry. J Neurol Neurosurg Psychiatry. 2007; 78:610–614. PMID: 17088334.
crossref
25. Mon A, Durazzo TC, Abe C, Gazdzinski S, Pennington D, Schmidt T, et al. Structural brain differences in alcohol-dependent individuals with and without comorbid substance dependence. Drug Alcohol Depend. 2014; 144:170–177. PMID: 25263262.
crossref
26. Moran C, Phan TG, Chen J, Blizzard L, Beare R, Venn A, et al. Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care. 2013; 36:4036–4042. PMID: 23939539.
crossref
27. Muthukumar N, Swaminathan R, Venkatesh G, Bhanumathy SP. A morphometric analysis of the foramen magnum region as it relates to the transcondylar approach. Acta Neurochir (Wien). 2005; 147:889–895. PMID: 15924208.
crossref
28. Natsis K, Piagkou M, Skotsimara G, Piagkos G, Skandalakis P. A morphometric anatomical and comparative study of the foramen magnum region in a Greek population. Surg Radiol Anat. 2013; 35:925–934. PMID: 23620089.
crossref
29. Niccolini F, Politis M. Neuroimaging in Huntington's disease. World J Radiol. 2014; 6:301–312. PMID: 24976932.
crossref
30. Raam MS, Solomon BD, Shalev SA, Muenke M. Holoprosencephaly and craniosynostosis: a report of two siblings and review of the literature. Am J Med Genet C Semin Med Genet. 2010; 154C:176–182. PMID: 20104614.
crossref
31. Rais M, Cahn W, Schnack HG, Hulshoff Pol HE, Kahn RS, van Haren NE. Brain volume reductions in medication-naive patients with schizophrenia in relation to intelligence quotient. Psychol Med. 2012; 42:1847–1856. PMID: 22357376.
crossref
32. Reite M, Reite E, Collins D, Teale P, Rojas DC, Sandberg E. Brain size and brain/intracranial volume ratio in major mental illness. BMC Psychiatry. 2010; 10:79. PMID: 20937136.
crossref
33. Stevens RD, Huff JS, Duckworth J, Papangelou A, Weingart SD, Smith WS. Emergency neurological life support: intracranial hypertension and herniation. Neurocrit Care. 2012; 17 Suppl 1:S60–S65. PMID: 22936079.
crossref
34. Sullivan EV, Mathalon DH, Lim KO, Marsh L, Pfefferbaum A. Patterns of regional cortical dysmorphology distinguishing schizophrenia and chronic alcoholism. Biol Psychiatry. 1998; 43:118–131. PMID: 9474444.
crossref
35. Tamrazi B, Almast J. Your brain on drugs: imaging of drug-related changes in the central nervous system. Radiographics. 2012; 32:701–719. PMID: 22582355.
crossref
36. Tubbs RS, Bosmia AN, Cohen-Gadol AA. The human calvaria: a review of embryology, anatomy, pathology, and molecular development. Childs Nerv Syst. 2012; 28:23–31. PMID: 22120469.
crossref
37. Wolf H, Kruggel F, Hensel A, Wahlund LO, Arendt T, Gertz HJ. The relationship between head size and intracranial volume in elderly subjects. Brain Res. 2003; 973:74–80. PMID: 12729955.
crossref
38. Zdilla MJ, Russell ML, Bliss KN, Mangus KR, Koons AW. The size and shape of the foramen magnum in man. J Craniovertebr Junction Spine. 2017; 8:205–221. PMID: 29021672.
crossref
TOOLS
Similar articles